Human osteocalcin: a strong promoter for nitric oxide synthase gene therapy, with specificity for hormone refractory prostate cancer

Medicine and Dentistry

• Gene Therapy 100%
• Promoter Region 100%
• Osteocalcin 100%
• Inducible Nitric Oxide Synthase 100%
• Nitric Oxide Synthase 100%
• Androgen 40%
• Genetic Transfection 30%
• Nitrite 20%
• Transgene 20%
• In Vitro 10%
• Western Blot 10%
• Cancer Cell 10%
• Target Cell 10%
• Endothelial Cell 10%
• Cytotoxicity 10%
• Cell Survival 10%
• Prostate Cancer Cell Line 10%
• Plasmid 10%
• Colon Carcinoma 10%
• Carcinoma Cell 10%
• Plasmid DNA 10%
• Clonogenic Assay 10%
• Tumor 10%

Biochemistry, Genetics and Molecular Biology

• Promoter Region 100%
• Gene Therapy 100%
• Osteocalcin 100%
• Nitric Oxide Synthase 100%
• Transfection 27%
• LNCaP 27%
• Cancer Cell 18%
• Plasmid 18%
• Transgene 18%
• Cell Survival 9%
• Colon 9%
• Western Blot 9%
• Cationic Lipid 9%
• Cytotoxicity 9%
• Target Cell 9%
• Clonogenic Assay 9%

Immunology and Microbiology

• Promoter Region 100%
• Nitric Oxide Synthase 100%
• Genetic Transfection 27%
• Prostate 18%
• Plasmid 18%
• Transgene 18%
• Prostate Cancer Cell Line 9%
• Cytotoxicity 9%
• Western Blot 9%
• Carcinoma Cell 9%
• Colon 9%
• Cell Survival 9%
• Cancer Cell 9%
• Target Cell 9%
• Clonogenic Assay 9%
• Cell Specificity 9%
• DU145 Cell Line 9%
• Prostate Cell Line 9%
• In Vitro 9%